06
Jul
2009
Posted in I - Series B, Q - 2Q09, R - NORTH EAST, X - Device (Cardiology), XX - PA
Embrella Cardiovascular (Malvern, PA) an early-stage medical device company focused on cerebral embolic protection during cardiovascular procedures, closed a $5.1M Series B financing. Participants include BioStarVentures, Edwards Lifesciences and MedFocus Fund.